Clinical Roundup NEJM phase III trial of Lonsurf + bevacizumab in CRC shows OS and PFS increases in mCRC May 05, 2023Vol.49 No.18
Clinical Roundup Elahere demonstrates OS benefit in the phase III MIRASOL trial in FRα-positive, platinum-resistant ovarian cancer May 05, 2023Vol.49 No.18
Clinical Roundup Breast cancer tumors disrupt the immune system remotely favoring their own growth, animal study suggests May 05, 2023Vol.49 No.18
Clinical Roundup Two-year follow-up indicates that sotorasib prolongs survival in NSCLC April 28, 2023Vol.49 No.17
Clinical Roundup Roswell Park immunologists identify targetable strategy for reducing solid-tumor cancer metastasis April 28, 2023Vol.49 No.17
Clinical Roundup ImmunityBio, NCI open first cancer prevention study to assess vaccines for Lynch Syndrome April 28, 2023
Clinical Roundup Pivotal trial results show Lumicell DVS finds residual cancer left behind during lumpectomy April 28, 2023Vol.49 No.17
Clinical Roundup World’s largest genomic study of canine cancer reveals potential for novel human cancer treatments April 28, 2023Vol.49 No.17
Clinical Roundup UCLA researchers use “rapid autopsies” to identify lethal molecular alterations in relapsed metastatic melanoma April 28, 2023Vol.49 No.17
